Try our Advanced Search for more refined results

Expert Analysis

Protecting Trade Secrets Disclosed To The FDA

By Douglas Nemec, William Casey and Tara Melillo (February 13, 2018, 10:50 AM EST) -- While intellectual property is a key value driver for most every company, in the life sciences industry, intellectual property is paramount. It provides for periods of market exclusivity and allows companies to differentiate their offerings from those of competitors. Given regulatory approval time lines that can take more than a decade and development costs that can exceed one billion dollars, strong intellectual property protection is necessary to ensure business viability. See, e.g., Costs to Develop and Win Marketing Approval for a New Drug Is $2.6 Billion, Tufts Center for the Study of Drug Dev. (Nov. 18, 2014), here....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!